To synthesize the long-term comparative efficacy of sleeve gastrectomy (SG) versus Roux-en-Y gastric bypass (RYGB) by reviewing and pooling data from studies with 10-year follow-up outcomes, focusing on weight loss and comorbidity remission.
Key Findings:
No statistically significant difference in total weight loss (%TWL) between SG and RYGB.
No statistically significant difference in excess weight loss (%EWL) between SG and RYGB.
Slight non-significant advantage for gastric bypass in both primary weight loss metrics.
Similar remission rates for comorbidities were observed, but specific data were not statistically significant.
Interpretation:
The findings suggest that while RYGB may have slight advantages in weight loss metrics, these differences are not statistically significant over a 10-year follow-up.
Limitations:
Limited number of studies with 10-year follow-up.
Moderate heterogeneity in outcomes, which may affect the reliability of the pooled results.
Conclusion:
Both SG and RYGB appear to have similar long-term outcomes in terms of weight loss and comorbidity remission, with no significant differences observed.
